Hepatocellular carcinoma: Epidemic and treatment
- Cite this article as:
- Allen, J. & Venook, A. Curr Oncol Rep (2004) 6: 177. doi:10.1007/s11912-004-0047-9
- 32 Downloads
Hepatocellular carcinoma remains a worldwide epidemic. Survival rates are poor; however, oncologists are able to offer regional therapies to those patients who present with early disease. Prevention through vaccination remains a mainstay of this epidemic. New staging systems that incorporate important information about tumor characteristics and liver disease improve our ability to prognosticate and treat these patients.